- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Obesity
Volume 2011 (2011), Article ID 751063, 1 page
Pharmacologic Treatment of Obesity
1University of São Paulo, 05508 São Paulo, SP, Brazil
2Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA
3University of Antwerp, 2650 Edegem/Antwerp, Belgium
Received 26 February 2012; Accepted 26 February 2012
Copyright © 2011 Alfredo Halpern et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The pharmacological treatment of obesity still faces many barriers. Notably, these include the disregard of obesity as a disease and the very limited treatment options for obesity. In this context, this special issue is of special importance as it focuses on several topics, related to this challenge.
After careful screening, review, and revision, we selected 26 articles which deal with a variety of aspects related to the pharmacological therapy of obesity. Topics covered include possible etiologies of the disease (e.g., A. Niijima’s rat study and B. Bjorndal et al.’s research on adipogenesis), the role of diet as an anti-inflammatory mediator (studies of B. Sears and C. Ricordi and W. R. Hamilton et al.), some new aspects of the drugs being used today, particularly orlistat (A. Hollywood and J. Ogden, J. Martin et al., and N. J. Perera et al. studies), and outlining the treatment of special conditions such as in children and adolescents (L. Iughett et al.), polycystic ovary syndrome (H. Kahal et al.), and diabetes mellitus (V. Cheng and S. R. Kashyap). Additional reports include reviews on the pharmacological treatment of obesity in the present and future (M. Glandt and I. Raz and L. L. Ioannides-Demos et al.).
To conclude, this edition of the journal describing advances in the pharmacological treatment of obesity will provide those in the field with new and useful insights on obesity pathogenesis and management.
Steven B. Heymsfield
Luc Van Gaal